Solubility of rofecoxib in the presence of mannitol, poly(vinylpyrrolidone) K30, urea, polyethylene glycol 4000, and polyethylene glycol 6000 at (298.15, 303.15, and 308.15) K

Journal of Chemical and Engineering Data

Volumn 50, Issue 2, 2005, Pages 661-665

  Liu, Chengsheng ^a   Desai, Kashappa Goud H ^a   Liu, Chenguang ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; DERIVATIVES; DISPERSIONS; FREE ENERGY; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; POLYETHYLENE GLYCOLS; SOLUBILITY; SUBSTITUTION REACTIONS; UREA;

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC); HYDROPHOBIC CARRIERS; MANNITOL; SOLID DISPERSIONS;

SOLUTIONS;

EID: 15844411900     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je049631p     Document Type: Article

References (12)

1. Leuner, C.; Dressman, J. Improving Drug Solubility for Oral Delivery Using Solid Dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
2. Hoerter, D.; Dressman, J. B. Influence of Physiochemical Properties on Dissolution of Drugs in the Gastrointestinal Tract (review). Adv. Drug. Delivery Rev. 1987, 25, 3-14.
3. Strickley, R. G. Solubilizing Excipients in Oral and Injectable Formulations. Pharm. Res. 2004, 21, 201-230.
4. Mani, N.; Jun, H. W.; Beach, J. W.; Nerukar, J. Solubility of Guaifenesin in the Presence of Common Pharmaceutical Additives. Pharm. Dev. Technol. 2003, 8, 385-396.
5. Tang, L.; Khan, S. U.; Muhammad, N. A. Evaluation and Selection of Bio-Relevant Dissolution Media for a Poorly Water-Soluble New Chemical Entity. Pharm. Dev. Technol. 2001, 6, 631-640.
6. Liu, C.; Dosai, K. G. H.; Liu, C. Solubility of Valdecoxib in the Presence of Polyethylene Glycol 4000, Polyethylene Glycol 6000, Polyethylene Glycol 8000, and Polyethylene Glycol 10 000 at (298.15, 303.15, and 308.16) K. J. Chem. Eng. Data 2005, 50, 278-282.
7. Dosai, K. G. H.; Kulkarni, A. R.; Aminabhavi, T. M. Solubility of Rofecoxib in the Presence of Methanol, Ethanol, and Sodium Lauryl Sulfate at (298.16, 303.16, and 308.15) K. J. Chem. Eng. Data. 2003, 48, 942-945.
8. Needleman, P.; Isakson, P. C. The Discovery and Function of Cox-2. J. Rheumatol. 1997, 24, 2-7.
9. Dannhardt, G.; Kiefer, W. Cycloozygenase Inhibitors-Current Status and Future Prospects. Eur. J. Med. Chem. 2001, 36, 109-126.
10. Liu. C.; Desai, K. G. H.; Liu. C. Solubility of Valdecoxib in the Presence of Ethanol and Sodium Lauryl Sulfate at (298.15, 303.15, and 308.16) K. J. Chem. Eng. Data. 2004, 49, 1847-1860.
11. Ajithadas, P.; Anusuya, P.; Balamariappan, C.; Lakshmanan, K.; Manikkavali, K.; Nanjappan, P. A. K. Reverse Phase High Performance Liquid Chromatographic Determination of Rofecoxib in Tablets. Indian Drugs 2001, 38, 523-525.
12. Damian, F.; Blaton, N.; Naesens, L.; Balzarini, J.; Kinget, R.; Augustinjns, P.; Mooter, G. V. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 2000, 10, 311-322.